Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies with a purpose to deliver next-generation and game-changing immuno-oncology therapies to patients living with cancer.
- http://www.laevoroc.com
- info@laevoroc.com
- Dr. Thomas Mehrling, CEO